Value Stock - Dividend - Research Selection
ISIN: , WKN:
Market price date:
Market price:
Market price:
Fundamental data and company key figures of the share
| Annual reports in | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key figures | |||||||||||||||||||||||||||||||||||||||||||||||||
| Cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net operating cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Expenditures | |||||||||||||||||||||||||||||||||||||||||||||||||
| Free cash flow | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance sheet | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Liabilities & Shareholders equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Income statement | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net income | |||||||||||||||||||||||||||||||||||||||||||||||||
| Eps (diluted) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Diluted shares outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales/revenue | |||||||||||||||||||||||||||||||||||||||||||||||||
Do you want to do make a detailed fundamental analysis of this stock?
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
| Description | Data |
|---|---|
| Symbol | |
| Market Capitalization | USD |
| Country | |
| Indices | |
| Sectors | |
| Raw Data Source | |
| Stock Split | |
| Internet |
Description of the company
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,
NEWS
Great news for Smith & Nephew plc (LON:SN.): Insiders acquired stock in large numbers last year
2022-11-24
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
15 Biggest Medical Device Companies in the World
2022-11-20
In this article, we will take a look at the 15 biggest medical device companies in the world. If you want to skip our introduction to the industry, then take a look at 5 Biggest Medical Device Companies in the World. The medical device market comprises companies that manufacture equipment used in diagnosing, treating and surveillance […]
Be Wary Of Smith & Nephew (LON:SN.) And Its Returns On Capital
2022-11-09
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...
Smith+Nephew Academy Singapore opens, bringing medical education and digital innovation to healthcare professionals across Asia-Pacific
2022-11-09
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the opening of Smith+Nephew (S+N) Academy Singapore, a major medical education and digital innovation centre covering the Asia-Pacific region today, in the presence of Mr Gan Kim Yong, Minister for Trade and Industry Singapore, Mr Alex Bamford, Deputy British High Commissioner to Singapore, and Smith+Nephew Chief Executive Officer Deepak Nath.
Smith & Nephew plc (SNN) Q3 2022 Earnings Call Transcript
2022-11-05
Smith & Nephew plc (NYSE:NYSE:SNN) Q3 2022 Results Conference Call November 03, 2022 04:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief...
Smith+Nephew expands procedural innovation with introduction of JOURNEY™ II ROX™ Total Knee Solution
2022-11-01
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of its JOURNEY II ROX Total Knee Solution – a reverse hybrid construct for total knee arthroplasty. This new procedural product solution aims to provide surgeons with the clinical advantage of an advanced bearing material and anatomic design combined with the efficiency1 and potential long-term tibia fixation of a cementless knee.
Investors in Smith & Nephew (LON:SN.) have unfortunately lost 36% over the last three years
2022-10-18
Many investors define successful investing as beating the market average over the long term. But if you try your hand...
10 Best FTSE Dividend Stocks To Buy Now
2022-10-17
In this article, we discuss 10 best FTSE dividend stocks to buy now. If you want to see more stocks in this selection, check out 5 Best FTSE Dividend Stocks To Buy Now. The Office for National Statistics reported that the U.K. economy contracted by 0.3% in August, potentially initiating a long recession that can […]
Palm Valley Capital Fund Q3 2022 Commentary
2022-10-15
The Palm Valley Capital Fund declined 1.83% during Q3 ending September 30, 2022. Click here to read the full fund letter.
Palm Valley Capital: “Smith & Nephew (SNN) is a High-Quality Business”
2022-10-12
Palm Valley Capital Management, an investment management firm, published its third-quarter 2022 investor letter – a copy of which can be downloaded here. A quarterly portfolio return of -1.83% was recorded by the fund for the third quarter of 2022, while its benchmarks, the S&P SmallCap 600 Index, by comparison, returned -5.20%, and -3.75% return […]